SARS-CoV-2 infection produces an IL-33-dependent chronic eosinophilic pneumonia and muco-inflammatory airways disease in mice
Padraig Hawkins(University of North Carolina at Chapel Hill), Richard C. Boucher(University of North Carolina at Chapel Hill), Stephen A. Schworer(Tufts University), Ralph S. Baric(University of North Carolina at Chapel Hill), Hong Dang(University of North Carolina at Chapel Hill), Robert S. Hagan(University of North Carolina at Chapel Hill), Lisa C. Morton(University of North Carolina at Chapel Hill), Sarah R. Leist(University of North Carolina at Chapel Hill), Rodney C. Gilmore(University of North Carolina at Chapel Hill), Kenichi Okuda(University of North Carolina at Chapel Hill), James J. Pestka(Michigan State University), Alessandra Livraghi-Butrico(University of North Carolina at Chapel Hill), Minako Saito(University of North Carolina at Chapel Hill), Lauren K. Heine, Alexandra Schäfer(University of North Carolina at Chapel Hill), Raymond J. Pickles(University of North Carolina at Chapel Hill), W K O’Neal(Johns Hopkins University), E F Burns(University of North Carolina at Chapel Hill), Jason R. Rock(Gene Therapy Laboratory), Jack R. Harkema(Michigan State University)
Cited by 0
Related Papers
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k
Basal cells as stem cells of the mouse trachea and human airway epithelium
|Proceedings of the National Academy of Sciences|2009|1.6k
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k